We are drawn to the difficult problems, the ones for which prevailing science does not yet have a framework to understand. Our strength is in developing new paradigms to tackle these problems and opening new avenues to transform human health.
Excellence in Scientific Discovery
A commitment to scientific discovery is one of Stanford Medicine's defining strengths. In ways that cannot be anticipated, the knowledge generated by unfettered exploration yields the building blocks for tomorrow's revolutionary clinical applications.
Researchers and clinician-scientists at Stanford Medicine work across disciplines to expand the frontiers of scientific understanding while moving the most promising breakthroughs into tangible health benefits through clinical trials.
With access to the resources of Stanford University -- including the Schools of Engineering, Law, Business, Humanities & Sciences and Education -- Stanford Medicine enables close interactions between physicians and scientists, faculty and trainees, and basic science and clinical care.
Discovery & Innovation to Improve Human Health
Faculty research across the basic and clinical sciences is helping to unlock tomorrow's medical breakthroughs.
Stanford Medicine researchers are screening diagnostic samples to identify known coronavirus variants circulating in the Bay Area, including those from the United Kingdom, South Africa and Brazil.
Scientists have identified a key factor in mental aging and shown that it might be prevented or reversed by fixing a glitch in the immune system’s front-line soldiers.
Stanford Medicine accepts hundreds of patient transfers to relieve regional hospitals during pandemic
The transfers occurred as part of a mutual aid agreement among local and regional hospitals as COVID-19 cases surge.
COVID-19 vaccination rates must reach 80% to achieve herd immunity, but only about 60% of Americans are willing to be vaccinated, according to the Pew Research Center. Stanford physician and economist Kevin Schulman suggests marketing tactics to boost compliance.
A comprehensive study of immune responses to SARS-CoV-2 associates mild disease with comparatively high levels of antibodies that target the viral spike protein. But all antibodies wane within months.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health and developing the next generation of care that is proactive, predictive and precise.